These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8492137)

  • 1. Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
    Faucheux BA; Hirsch EC; Villares J; Selimi F; Mouatt-Prigent A; Javoy-Agid F; Hauw JJ; Agid Y
    J Neurochem; 1993 Jun; 60(6):2338-41. PubMed ID: 8492137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
    Faucheux BA; Hauw JJ; Agid Y; Hirsch EC
    Brain Res; 1997 Feb; 749(1):170-4. PubMed ID: 9070646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
    Faucheux BA; Herrero MT; Villares J; Levy R; Javoy-Agid F; Obeso JA; Hauw JJ; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 691(1-2):115-24. PubMed ID: 8590043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin receptors in the parkinsonian midbrain.
    Morris CM; Candy JM; Omar S; Bloxham CA; Edwardson JA
    Neuropathol Appl Neurobiol; 1994 Oct; 20(5):468-72. PubMed ID: 7845532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
    Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC
    Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and distribution of transferrin receptors in the rat brain.
    Mash DC; Pablo J; Flynn DD; Efange SM; Weiner WJ
    J Neurochem; 1990 Dec; 55(6):1972-9. PubMed ID: 2230804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
    Kastner A; Hirsch EC; Herrero MT; Javoy-Agid F; Agid Y
    J Neurochem; 1993 Sep; 61(3):1024-34. PubMed ID: 8103078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiography of transferrin receptors in the human brain.
    Griffiths PD; Crossman AR
    Neurosci Lett; 1996 Jun; 211(1):53-6. PubMed ID: 8809846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.
    Villares J; Faucheux B; Strada O; Hirsch EC; Agid Y; Javoy-Agid F
    Brain Res; 1993 Nov; 628(1-2):72-6. PubMed ID: 8313172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
    Leveugle B; Faucheux BA; Bouras C; Nillesse N; Spik G; Hirsch EC; Agid Y; Hof PR
    Acta Neuropathol; 1996; 91(6):566-72. PubMed ID: 8781654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization.
    German DC; Manaye K; Smith WK; Woodward DJ; Saper CB
    Ann Neurol; 1989 Oct; 26(4):507-14. PubMed ID: 2817827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.
    Counihan TJ; Penney JB
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):164-9. PubMed ID: 9703165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
    Damier P; Kastner A; Agid Y; Hirsch EC
    Neurology; 1996 May; 46(5):1262-9. PubMed ID: 8628464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
    Kastner A; Hirsch EC; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
    J Neurochem; 1992 Sep; 59(3):1080-9. PubMed ID: 1494900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
    Mouatt-Prigent A; Karlsson JO; Yelnik J; Agid Y; Hirsch EC
    J Comp Neurol; 2000 Apr; 419(2):175-92. PubMed ID: 10722997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains.
    Inagaki S; Kito S; Kubota Y; Girgis S; Hillyard CJ; MacIntyre I
    Brain Res; 1986 May; 374(2):287-98. PubMed ID: 3013366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
    Taquet H; Javoy-Agid F; Cesselin F; Hamon M; Legrand JC; Agid Y
    Brain Res; 1982 Mar; 235(2):303-14. PubMed ID: 7188329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.